Esterase-Responsive Fluorogenic Prodrugs of Aldose Reductase Inhibitor Epalrestat: An Innovative Strategy toward Enhanced Anticancer Activity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Esterase-Responsive Fluorogenic Prodrugs of Aldose Reductase Inhibitor Epalrestat: An Innovative Strategy toward Enhanced Anticancer Activity

Published:2024-08-15 Issue: Volume: Page:
ISSN:2576-6422
Container-title:ACS Applied Bio Materials
language:en
Short-container-title:ACS Appl. Bio Mater.

Author:

Misra Roopjyoti¹,Barman Pallavi¹,Bhabak Krishna P.¹^ORCID

Affiliation:

1. Department of Chemistry, Indian Institute of Technology Guwahati, Guwahati 781039, Assam, India

Funder

Council of Scientific and Industrial Research, India

Indian Institute of Technology Guwahati

Science and Engineering Research Board

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsabm.4c00719

Reference52 articles.

1. Metabolism and Epigenetic Interplay in Cancer: Regulation and Putative Therapeutic Targets

2. Metabolic reprogramming in cervical cancer and metabolomics perspectives

3. Metabolic profiling reveals key metabolic features of renal cell carcinoma

4. Metabolic Reprogramming in Gastric Cancer: Trojan Horse Effect

5. Metabolic Vulnerabilities in Endometrial Cancer

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP